Skip to main content
. 2025 Feb 11;85(6):549–557. doi: 10.5935/0004-2749.202200100

Table 2.

Characteristics of the study population

Variables Women n (%) Men n (%) Total subjects n (%)
Total 417(71.65) 165 (28.35) 582
Age (yrs)
<55 135 (32.37) 32 (19.39) 167 (28.69)
55-75 231 (55.40) 104 (63.03) 335 (57.56)
>75 51 (12.23) 29 (17.58) 80(13.75)
Education
Incomplete fundamental 90 (21.58) 42 (25.46) 132 (22.68)
Complete fundamental 130 (31.18) 56 (33.94) 186 (31.96)
Incomplete secondary 29 (6.95) 11 (6.67) 40 (6.87)
Complete secondary 108 (25.90) 43 (26.06) 151 (25.94)
Incomplete superior 12 (2.88) 6 (3.64) 18 (3.09)
Complete superior 48 (11.51) 7 (4.24) 55 (9.45)
Race/ethnicity
White 256 (61.39) 84 (50.91) 340 (58.42)
African American 28 (6.72) 15 (9.09) 43 (7.39)
Mixed (Mulatto/Pardo) 124 (29.74) 60 (36.36) 184 (31.62)
Asian 5(1.20) 5 (3.03) 10(1.72)
Native American 4 (0.96) 1 (0.61) 5 (0.86)
Computer use 27 (6.48) 8 (4.85) 35 (6.01)
Cigarrette smoking 107 (25.66) 74 (44.85) 181 (31.10)
Diabetes (type 11) 85 (20.38) 31 (18.79) 116 (19.93)
Cardiopathy 35 (8.39) 18 (10.91) 53 (9.11)
Hypertension 223 (53.48) 85 (51.51) 308 (52.92)
Rheumatism 43 (10.31) 8 (4.85) 51 (8.76)
Depression medication 37 (8.87) 9 (5.45) 46 (7.90)
Allergy medication 50(11.99) 9 (5.45) 59 (10.14)
Contact lenses users 6 (1.44) 0 (0.00) 6(1.03)
Eye drop users 98 (23.50) 32 (19.40) 130 (22.34)